Giant Gastric Gastrointestinal Stromal Tumor (GIST)

J Gastrointest Surg. 2017 Jan;21(1):202-204. doi: 10.1007/s11605-016-3196-x. Epub 2016 Jul 6.

Abstract

Gastrointestinal stromal tumors (GIST) represent 0.1-3 % of gastrointestinal malignancy. Surgery is the mainstay of treatment, but in high-risk tumors, imatinib can help to achieve better oncological outcomes. We present a rare case of a patient with gastric GIST with very aggressive evolution in a short period of time despite the use of neoadjuvant therapy with imatinib.

Keywords: GIST; Gastric; Imatinib.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Female
  • Gastrointestinal Neoplasms / diagnostic imaging
  • Gastrointestinal Neoplasms / drug therapy*
  • Gastrointestinal Neoplasms / surgery
  • Gastrointestinal Stromal Tumors / diagnostic imaging
  • Gastrointestinal Stromal Tumors / drug therapy*
  • Gastrointestinal Stromal Tumors / surgery
  • Humans
  • Imatinib Mesylate / therapeutic use*
  • Middle Aged
  • Neoadjuvant Therapy*
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents
  • Imatinib Mesylate